Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin

Multidrug resistance(MDR) is a major obstacle to efficiency of breast cancer chemotherapy. We investigated whether combination of metformin and 2-deoxyglucose reverses MDR of MCF-7/Dox cells and tried to elucidate the possible mechanisms. The combination of metformin and 2-deoxyglucose selectively e...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Chaojun, Wang, Changyuan, Sun, Yaoting, Meng, Qiang, Liu, Zhihao, Huo, Xiaokui, Sun, Pengyuan, Sun, Huijun, Ma, Xiaodong, Ma, Xiaochi, Peng, Jinyong, Liu, Kexin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352427/
https://www.ncbi.nlm.nih.gov/pubmed/28052008
http://dx.doi.org/10.18632/oncotarget.14373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352427/
https://www.ncbi.nlm.nih.gov/pubmed/28052008
http://dx.doi.org/10.18632/oncotarget.14373

Ejemplares similares